Skip to content

Haemonetics HAE Net Income

Net Income at other companies

Abbott logo
AbbottABT
$1.08B-18.7%
TFX
TeleflexTFX
-$8.15M-109%
Boston Scientific logo
Boston ScientificBSX
$1.34B+99.3%
Medtronic logo
MedtronicMDT
$1.26B+18.7%
LivaNova logo
LivaNovaLIVN
$22.29M+107%
ICU Medical logo
ICU MedicalICUI
$30.13M+295%

Other financials

Income statement

See full
Revenue$346.4M+4.8%
Gross profit$198.2M+2.7%
Operating income$67.4M+14.2%
Net income$44.7M+19.3%
EPS (diluted)$0.95+28.4%

Balance sheet

See full
Cash & equivalents$245.4M-20.0%
Total debt$1.3B-0.7%
Total equity$796.3M-3.0%
Total assets$2.4B-2.2%

Cash flow

See full
Operating cash flow$70.9M-39.1%
CapEx$17.7M+12.9%
Free cash flow$53.3M-47.2%

Valuation

See full
Market cap$3.31B-18.0%

Profitability

See full
Gross margin59%+4.0pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin19.5%+9.1pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.6×0.0×
Current ratio+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Haemonetics’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Haemonetics's net income?
Haemonetics (HAE) reported net income of $44.74M in Q4 2025.
How has Haemonetics's net income changed year-over-year?
Haemonetics's net income increased by 19.3% year-over-year, from $37.49M to $44.74M.
What is the long-term trend for Haemonetics's net income?
Over 3 years (2022 to 2025), Haemonetics's net income has grown at a 56.9% compound annual growth rate (CAGR), from $43.38M to $167.68M.
What does net income mean?
Net income as the starting point for the indirect method operating cash flow reconciliation.